Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octane SCHEMBL27624 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Undecane SCHEMBL27865572 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Octane SCHEMBL8554735 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Decane SCHEMBL28102289 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Nonane SCHEMBL27865569 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Undecane SCHEMBL28453375 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Heptane SCHEMBL28681950 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Heptane SCHEMBL28458543 | 1.00 | TSHR (0.67) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Octane SCHEMBL29415664 | 0.96 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| Decane SCHEMBL7073253 | 0.96 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260081-B | Sulfonamide indole aryl sulfone derivative and preparation method and application thereof | 山东大学 | 2024-04-02 | — | — | CN | claimed |
| CN-112920208-B | Boric acid-containing indole aryl sulfone derivative and preparation method and application thereof | 山东大学 | 2022-11-08 | — | — | CN | claimed |
| CN-115260081-A | Sulfonamide indole aryl sulfone derivative and preparation method and application thereof | 山东大学 | 2022-11-01 | — | — | CN | claimed |
| CN-111943901-B | Method for directly synthesizing oxazolidine-2, 4-diketone heterocyclic compound from alkynylamide | 南京工业大学 | 2022-10-11 | — | — | CN | claimed |
| CN-111909993-B | Molecular probe of isoprene modified biomolecule and application thereof | 华中科技大学 | 2022-03-25 | — | — | CN | claimed |
| CN-110343123-B | Hybrid copper iodide and synthetic method and application thereof | 安阳师范学院 | 2022-03-15 | — | — | CN | claimed |
| CN-112898188-B | Method for preparing alpha-acyloxy thioether derivative | 常州大学 | 2022-03-08 | — | — | CN | claimed |
| CN-113912548-A | Abelide and preparation method of intermediate thereof | 浙江师范大学行知学院 | 2022-01-11 | — | — | CN | claimed |
| WO-2022000868-A1 | INTERMEDIATE FOR SYNTHESIZING CAMPTOTHECIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海皓元生物医药科技有限公司 | 2022-01-06 | — | — | WO | claimed |
| CN-112920208-A | Boric acid-containing indole aryl sulfone derivative and preparation method and application thereof | 山东大学 | 2021-06-08 | — | — | CN | claimed |
| EP-3126545-A2 | DECARBOXYLATIVE CROSS-COUPLING AND APPLICATIONS THEREOF | The Trustees of Princeton University (US) | 2017-02-08 | — | — | EP | claimed |
| WO-2015153381-A2 | DECARBOXYLATIVE CROSS-COUPLING AND APPLICATIONS THEREOF | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2015-10-08 | — | — | WO | claimed |
| EP-2122418-B1 | STRIPPER FOR COATING LAYER | AZ ELECTRONIC MATERIALS USA (US) | 2012-08-08 | — | — | EP | claimed |
| US-8026201-B2 | Comprising: a fluoride source, an organic quaternary ammonium base, and a solvent selected from an organic solvent, water, and mixtures thereof; for removing silicon-based anti-reflective coatings/hardmask layers from microelectronics; etch selectivity | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2011-09-27 | — | — | US | claimed |
| EP-2122418-A2 | STRIPPER FOR COATING LAYER | AZ Electronic Materials USA Corp. (US) | 2009-11-25 | — | — | EP | claimed |
| US-20080234506-A1 | PROCESS FOR THE PREPARATION OF FLUOROTETRAENE | DR. REDDY'S LABORATORIES LIMITED (IN) | 2008-09-25 | — | — | US | claimed |
| WO-2008081416-A2 | STRIPPER FOR COATING LAYER | AZ ELECTRONIC MATERIALS USA CORP. (DE) | 2008-07-10 | — | — | WO | claimed |
| EP-1207166-B1 | Process for the preparation of 6.alpha.-fluoro,9,11.beta.-epoxy-steroids | FARMABIOS SPA (IT) | 2007-09-26 | — | — | EP | claimed |
| US-20020062021-A1 | Process for the preparation of fluorosteroids | FARMABIOS S.P.A. (IT) | 2002-05-23 | — | — | US | claimed |
| EP-1207166-A2 | Process for the preparation of 6.alpha.-fluoro,9,11.beta.-epoxy-steroids | Farmabios S.r.l. (IT) | 2002-05-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234506-A1 | PROCESS FOR THE PREPARATION OF FLUOROTETRAENE | CYP17A1, CYP21A2, CYP19A1 | TSHR 806/4885THRB 590/4885DNM1 2451/4885 |
| US-20020062021-A1 | Process for the preparation of fluorosteroids | CYP46A1, HSD3B1, CYP17A1 | TSHR 573/4885THRB 783/4885DNM1 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.